Lumigan and Rocephin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lumigan (bimatoprost) and Rocephin (ceftriaxone sodium). Common drug interactions include enterobacter test positive among females and syncope among males.

The phase IV clinical study analyzes what interactions people have when they take Lumigan and Rocephin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Lumigan?

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

23 people who take Lumigan and Rocephin together, and have interactions are studied.

What are the common drug interactions of Lumigan and Rocephin, by gender? *:

female:

Enterobacter test positive
Fluid overload (too much fluid in the blood)
Fracture
Fungal infection
Gastric disorder (disease of stomach)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
General physical health deterioration (weak health status)
Haemoglobin decreased
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Histoplasmosis (infection caused by breathing in spores of a fungus)

male:

Syncope (loss of consciousness with an inability to maintain postural tone)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pleural effusion (water on the lungs)
Anaemia (lack of blood)
Confusional state
Dehydration (dryness resulting from the removal of water)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hypoxia (low oxygen in tissues)
Loss of consciousness

What are the common drug interactions of Lumigan and Rocephin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Injury
International normalised ratio decreased
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Neck pain
Prothrombin time shortened
Pulmonary congestion (congestion in the lungs)
Renal failure (kidney dysfunction)
Sneezing
Tremor (trembling or shaking movements in one or more parts of your body)
Abdominal pain

60+:

Syncope (loss of consciousness with an inability to maintain postural tone)
Renal failure acute (rapid kidney dysfunction)
Septic shock (shock due to blood infection)
Diarrhoea
General physical health deterioration (weak health status)
Anaemia (lack of blood)
Confusional state
Dehydration (dryness resulting from the removal of water)
Disease progression
Drug hypersensitivity

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 39.13%
Stress And Anxiety: 7 people, 30.43%
Constipation: 7 people, 30.43%
Pain: 7 people, 30.43%
Diabetes: 6 people, 26.09%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 21.74%
Leukopenia (less number of white blood cells in blood): 5 people, 21.74%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 21.74%
Cardiac Failure Congestive: 4 people, 17.39%
Multiple Myeloma (cancer of the plasma cells): 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Lumigan and Rocephin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously